The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis

References

• Alexander-Sefre F, Singh N, Ayhan A, Thomas JM, Jacobs IJ. 2004. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer. Gynecologic Oncology 92:653–659.
   PubMedGoogle Scholar
• Ali A, Black D, Soslow RA. 2007. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. International Journal of Gynecological Pathology 26:115–123.
   PubMedGoogle Scholar
• Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. 2005. Endometrial cancer. Lancet 366:491–505.
   PubMed Web of Science ®Google Scholar
• Bokhman JV. 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 15:10–17.
   PubMed Web of Science ®Google Scholar
• Deligdisch L, Cohen CJ. 1985. Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 56:1452.
   PubMedGoogle Scholar
• Ellenson LH, Ronnett BM, Soslow RA, Zaino RJ, Kurman RJ. 2011. Endometrial carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein's pathology of the female genital tract. 6th ed. New York: Springer. p 393–452.
   Google Scholar
• Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D et al. 2013. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. American Journal of Surgical Pathology 37:1728–1736.
   PubMed Web of Science ®Google Scholar
• Guarino M, Rubino B, Ballabio G. 2007. The role of epithelial–mesenchymal transition in cancer pathology. Pathology 39:305–318.
   PubMed Web of Science ®Google Scholar
• Hertel JD, Huettner PC, Pfeifer JD. 2014. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis. International Journal of Gynecological Pathology 33:127–134.
   PubMedGoogle Scholar
• Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. 2007. Epithelial–mesenchymal and mesenchymal–epithelial transitions in carcinoma progression. Journal of Cellular Physiology 213:374–383.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Kaminski PF, Norris HJ. 1985. The behavior of endometrial hyperplasia. A longterm study of ‘untreated’ hyperplasia in 170 patients. Cancer 56:403.
   PubMed Web of Science ®Google Scholar
• Longacre TA, Hendrickson MR. 1999. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. American Journal of Surgical Pathology 23:69–78.
   PubMed Web of Science ®Google Scholar
• Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C et al. 2001. Molecular pathology of endometrial hyperplasia and carcinoma. Human Pathology 32:569–577.
   PubMed Web of Science ®Google Scholar
• Murray SK, Young RH, Scully RE. 2003. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems and prognostic significance. International Journal of Gynecological Pathology 22:324–333.
   PubMed Web of Science ®Google Scholar
• Mutch DG. 2009. The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas. Gynecologic Oncology 115:325–328.
   Google Scholar
• Pavlakis K, Messini I, Vrekoussis T, Panoskaltsis T, Chrysanthakis D, Yiannou P et al. 2011. MELF invasion in endometrial cancer as a risk factor for lymph node metastasis. Histopathology 58:966–973.
   PubMedGoogle Scholar
• Prall F. 2007. Tumour budding in colorectal carcinoma. Histopathology 50:151–162.
   PubMedGoogle Scholar
• Quick CM, May T, Horowitz NS, Nucci MR. 2012. Low-grade, low-stage endometrioid endometrial adenocarcinoma a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion. International Journal of Gynecological Pathology 31:337–343.
   PubMedGoogle Scholar
• Rubio CA. 2006. Cell proliferation at the invading leading front of colonic carcinomas. Preliminary observations. Anticancer Research 26:2275–2278.
   PubMedGoogle Scholar
• Rubio CA. 2007. Further studies on the arrest of cell proliferation in tumor cells at the invading front of colonic adenocarcinoma. Journal of Gastroenterology and Hepatology 22:1877–1881.
   PubMedGoogle Scholar
• Rubio CA. 2008. Morphologic and molecular events at the invading edge of colorectal carcinomas. International Journal of Clinical and Experimental Pathology 1:98–104.
   PubMedGoogle Scholar
• Scholten AN, Creutzberg CL, Noordijk EM, Smit VT. 2002. Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system. International Journal of Radiation Oncology, Biology, Physics 52:1067–1074.
   PubMedGoogle Scholar
• Shepherd JH. 1989. Revised FIGO staging for gynaecological cancer. Journal of Gynecologic Oncology 96:889–892.
   Google Scholar
• Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics, 2012. A Cancer Journal for Clinicians 62:10–29.
   PubMed Web of Science ®Google Scholar
• Stewart CJR, Little L. 2009. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial– mesenchymal transition. Histopathology 55:91–101.
   PubMed Web of Science ®Google Scholar
• Stewart CJ, Brennan BA, Leung YC, Little L. 2009a. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion. Pathology 41:454–459.
   PubMed Web of Science ®Google Scholar
• Stewart CJR, Crook ML, Leung YC, Platten M. 2009b. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Modern Pathology 22:725–733.
   PubMed Web of Science ®Google Scholar
• Stewart CJR, Amanuel B, Grieu F, Carrello A, Iacopetta B. 2010a. KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion. Journal of Clinical Pathology 63:604–608.
   PubMedGoogle Scholar
• Stewart CJR, Crook ML, Doherty DA. 2010b. Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma and inverse correlation between Ki-67 and cytokeratin 7 expression. Histopathology 57:46–54.
   PubMedGoogle Scholar
• Stewart CJ, Crook ML, Manso L. 2011. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin. Histopathology 59:73–80.
   PubMedGoogle Scholar
• Stewart CJ, McCluggage WG. 2013. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology 62:31–43.
   PubMedGoogle Scholar
• Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer 2:442–454.
   PubMed Web of Science ®Google Scholar